HomeRCUS ā¢ NYSE
Arcus Biosciences Inc
add
$9.70
2.02%
After Hours:(0.00%)0.00
$9.70
Closed: Mar 12, 4:03:02āÆPM UTC-4 Ā· USD Ā· NYSE Ā· Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 26.00M | -16.13% |
Operating expense | 28.00M | -3.45% |
Net income | -94.00M | -16.05% |
Net profit margin | -361.54 | -38.37% |
Earnings per share | -1.03 | 4.63% |
EBITDA | -100.00M | -13.64% |
Effective tax rate | -1.08% | ā |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 978.00M | 28.85% |
Total assets | 1.15B | 5.02% |
Total liabilities | 665.00M | 5.06% |
Total equity | 485.00M | ā |
Shares outstanding | 105.84M | ā |
Price to book | 1.88 | ā |
Return on assets | -21.44% | ā |
Return on capital | -39.98% | ā |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Dec 2024info | Y/Y change |
---|---|---|
Net income | -94.00M | -16.05% |
Cash from operations | -100.00M | -13.64% |
Cash from investing | 51.00M | 82.14% |
Cash from financing | -2.00M | -166.67% |
Net change in cash | -51.00M | 10.53% |
Free cash flow | -36.63M | 25.06% |
Previous close
$9.90
Day range
$9.42 - $9.98
Year range
$9.01 - $19.18
Market cap
887.66M USD
Avg Volume
1.16M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
2015
Website
Employees
627